Tuesday, October 15, 2024 from 1:15 PM to 4:30 PM MST at Convention Center North Building / Meeting Room 121
The Clinical Reasoning Series aims to deliver programs that will meaningfully contribute to advancing pharmacy specialists’ knowledge, skills, and clinical judgment. Topic selection for the program reflects content that is timely and of relevance and value to the practice of Board Pharmacotherapy Specialists (BCPS).
Participants will have the opportunity to attend four educational activities, broken into a two-part morning and a two-part afternoon session. Part Two will offer 3.0 contact hours of continuing pharmacy education credit toward BCPS recertification credit upon completing the required posttests by the submission deadline and achieving a predetermined passing score. The posttests will be available on November 6, 2024. The deadline to submit posttests and earn recertification credit for the session will be November 6, 2025. If you have not already purchased posttest access and wish to add it to your registration, email [email protected] or visit the registration desk on or before October 15, 2024.
 | | Moderator: | Kathleen Pincus, Pharm.D., BCACP, BCPS | | Associate Professor & PGY-2 Ambulatory Care Residency Program Director
University of Maryland School of Pharmacy
Baltimore, MD | | View Biography |
|
Management of Infectious Disease In Immigrant and Refugee Populations1:15 PM to 2:45 PM
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-155-L01-P
Activity Type: An Application-Based Activity
Immigrant and refugee populations have risk factors and exposures distinct from those in which they are receiving treatment. This presentation will review considerations for screening and diagnosis recommendations in this population and how resistance patterns influence treatment decisions. An analysis of overseas and domestic guidance recommendations for United States (US) bound refugees will be provided, something many practicing pharmacists may be unfamiliar with or lack access to. Management of tuberculosis and other relevant infections, such as H. pylori, will also be discussed. This presentation incorporates case-based questions, an opportunity to develop and/or modify treatment regimens, and practice exercises to enhance understanding. This activity offers 1.5 contact hours of CPE and/or BCPS recertification credit. Learning Objectives1. Review the definitions for the following: immigrant, refugee, migrant. 2. Analyze overseas and domestic guidance recommendations for United States (US) bound refugees. 3. Recommend a complete treatment regimen with a monitoring plan for a refugee with Helicobacter pylori (H. pylori) infection using recent literature and guideline recommendations. 4. Evaluate current guideline recommendations describing the use of medications for latent tuberculosis. 5. Formulate an alternative treatment regimen for commonly encountered intestinal parasites.  | | Speaker: | Kara L. Birrer, Pharm.D., BCPS | | Clinical Pharmacy Specialist, Neurocritical Care
Orlando Regional Medical Center / Orlando Health
Orlando, FL | | View Biography |
|
|
Break in Programming2:45 PM to 3:00 PM |
Beyond Endocarditis: Management of Cardiac Infections3:00 PM to 4:30 PM
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-158-L01-P
Activity Type: An Application-Based Activity
Beyond Endocarditis: Management of Cardiac Infections will provide a focused review of appropriate pharmacotherapeutic approaches to the management of patients with less commonly encountered cardiac infections, including myocarditis, pericarditis, cardiac device infections, vascular graft infections, and unusual bacterial/fungal causes of endocarditis. The presentation will include discussion of diagnostics, antimicrobial selection, treatment response monitoring, and considerations for relevant co-morbidities through use of case studies, including patients who use intravenous drugs. This activity offers 1.5 contact hours of CPE and/or BCPS recertification credit. Learning Objectives1. Summarize clinical characteristics and supportive management of pericarditis and myocarditis. 2. Compare therapeutic plans for cardiac device infections. 3. Differentiate between acute and long term management of vascular graft infections. 4. Recommend optimal treatment strategies for complex and uncommon causes of bacterial endocarditis (including Q fever, Histoplasmosis, and Bartonella). 5. Recognize updates in endocarditis management with special attention to diagnostics and patients who use IV drugs.  | | Speaker: | Kirstin J. Kooda, Pharm.D., BCCCP, BCIDP, BCPS | | Critical Care and Stewardship Pharmacist
Mayo Clinic
Rochester, MN | | View Biography |
|
|